Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice

Endocrinology

Volumn 146, Issue 9, 2005, Pages 3975-3984

  Bielinska, Malgorzata ^a   Genova, Elena ^a   Boime, Irving ^a   Parviainen, Helka ^b   Kiiveri, Sanne ^f   Leppäluoto, Juhani ^d   Rahman, Nafis ^c   Heikinheimo, Markku ^a,b   Wilson, David B ^a,e  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE

Author keywords

Adrenal tumor; Metaplasia; Ovariectomy; Steroidogenesis; Transdifferentiation; Xenograft

Indexed keywords

CHORIONIC GONADOTROPIN; CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450C17; CYTOCHROME P450C19; ESTRADIOL; INHIBIN A; LUTEINIZING HORMONE RECEPTOR; LYASE; MELANOCORTIN 2 RECEPTOR; OXYGENASE; STEROID 21 MONOOXYGENASE; TESTOSTERONE; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

ADRENAL CORTEX TUMOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SPECIFICITY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; GONADECTOMY; HORMONAL CARCINOGENESIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; TESTOSTERONE BLOOD LEVEL;

EID: 23844516455     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2004-1643     Document Type: Article

References (56)

1. Fidler WJ 1977 Ovarian thecal metaplasia in adrenal glands. Am J Clin Pathol 67:318-323
2. Werk EE, Jr., Sholiton LE, Kalejs L 1973 Testosterone-secreting adrenal adenoma under gonadotropin control. New England J Med 289:767-770
3. Givens JR, Andersen RN, Wiser WL, Coleman SA, Fish SA 1974 A gonadotropinresponsive adrenocortical adenoma. J Clin Endocrinol Metab 38:126-133
4. Carney JA 1987 Unusual tumefactive spindle-cell lesions in the adrenal glands. Hum Pathol 18:980-985
5. Romberger CF, Wong TW 1989 Thecal metaplasia in the adrenal gland of a man with acquired bilateral testicular atrophy. Arch Pathol Lab Med 113:1071-1075
6. Thompson GB, Young Jr WF 2003 Adrenal incidentaloma. Curr Opin Oncol 15:84-90
7. Bertherat J, Mosnier-Pudar H, Bertagna X 2002 Adrenal incidentalomas. Curr Opin Oncol 14:58-63
8. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J 2004 Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15:375-382
9. Russfield AB 1975 Experimental endocrinopathies. Methods Achiev Exp Pathol 7:132-148
10. Schoemaker NJ, Teerds KJ, Mol JA, Lumeij JT, Thijssen JH, Rijnberk A 2002 The role of luteinizing hormone in the pathogenesis of hyperadrenocorticism in neutered ferrets. Mol Cell Endocrinol 197:117-125
11. Firth CH, Dunn TB 1994 Tumours of the adrenal gland. IARC Sci Publ 111:595-609
12. Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, Parlow AF, Nilson JH, Hammer GD 2003 Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol Cell Biol 23:3951-3964
13. Mikola M, Kero J, Nilson JH, Keri RA, Poutanen M, Huhtaniemi I 2003 High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-α subunit promoter/Simian virus 40 T-antigen fusion gene. Oncogene 22:3269-3278
14. Murthy AS, Brezak MA, Baez AG 1970 Postcastrational adrenal tumors in two strains of mice: morphologic, histochemical, and chromatographic studies. J Natl Cancer Inst 45:1211-1222
15. Huseby RA, Bittner JJ 1951 Differences in adrenal responsiveness to post-castrational alteration as evidenced by transplanted adrenal tissue. Cancer Res 11:954-961
16. Stalvey JR, Payne AH 1983 Luteinizing hormone receptors and testosterone production in whole testes and purified Leydig cells from the mouse: differences among inbred strains. Endocrinology 112:1696-1701
17. Frigeri C, Tsao J, Cordova M, Schimmer BP 2002 A polymorphic form of steroidogenic factor-1 is associated with adrenocorticotropin resistance in Y1 mouse adrenocortical tumor cell mutants. Endocrinology 143:4031-4037
18. Morley SD, Viard I, Chung BC, Ikeda Y, Parker KL, Mullins JJ 1996 Variegated expression of a mouse steroid 21-hydroxylase/β-galactosidase transgene suggests centripetal migration of adrenocortical cells. Mol Endocrinol 10:585-598
19. Bielinska M, Parviainen H, Porter-Tinge SB, Kiiveri S, Genova E, Rahman N, Huhtaniemi IT, Muglia LJ, Heikinheimo M, Wilson DB 2003 Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor. Endocrinology 144:4123-4133
20. Peterson RA, Kiupel M, Bielinska M, Kiiveri S, Heikinheimo M, Capen CC, Wilson DB 2004 Transcription factor GATA-4 is a marker of anaplasia in adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Vet Pathol 41:446-449
21. Balciunaite G, Keller MP, Balciunaite E, Piali L, Zuklys S, Mathieu YD, Gill J, Boyd R, Sussman DJ, Hollander GA 2002 Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol 3:1102-1108
22. Rebar RW, Morandini IC, Erickson GF, Petze JE 1981 The hormonal basis of reproductive defects in athymic mice: diminished gonadotropin concentrations in prepubertal females. Endocrinology 108:120-126
23. Rebar RW, Morandini IC, Petze JE, Erickson GF 1982 Hormonal basis of reproductive defects in athymic mice: reduced gonadotropins and testosterone in males. Biol Reprod 27:1267-1276
24. Sugahara T, Pixley MR, Minami S, Perlas E, Ben Menahem D, Hsueh AJ, Boime I 1995 Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem. Proc Natl Acad Sci U S A 92:2041-2045
25. Ben Menahem D, Jablonka-Shariff A, Hyde RK, Pixley MR, Srivastava S, Berger P, Boime I 2001 The position of the alpha and beta subunits in a single chain variant of human chorionic gonadotropin affects the heterodimeric interaction of the subunits and receptor-binding epitopes. J Biol Chem 276:29871-29879
26. Haavisto AM, Pettersson K, Bergendahl M, Perheentupa A, Roser JF, Huhtaniemi I 1993 A supersensitive immunofluorometric assay for rat luteinizing hormone. Endocrinology 132:1687-1691
27. Anttonen M, Ketola I, Parviainen H, Pusa AK, Heikinheimo M 2003 FOG-2 and GATA-4 are coexpressed in the mouse ovary and can modulate Müllerian- inhibiting substance expression. Biol Reprod 68:1333-1340
28. Milstone DS, Shaw SK, Parker KL, Szyf M, Seidman JG 1992 An element regulating adrenal-specific steroid 21-hydroxylase expression is located within the slp gene. J Biol Chem 267:21924-21927
29. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR 1996 Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10:2577-2587
30. Honda S, Harada N, Takagi Y 1996 The alternative exons 1 of the mouse aromatase cytochrome P-450 gene. Biochim Biophys Acta 1305:145-150
31. Kim JS, Kubota H, Kiuchi Y, Doi K, Saegusa J 1997 Subcapsular cell hyperplasia and mast cell infiltration in the adrenal cortex of mice: comparative study in 7 inbred strains. Exp Anim 46:303-306
32. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2002 Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat Genet 32:408-410
33. Fynn-Thompson E, Cheng H, Teixeira J 2003 Inhibition of steroidogenesis in Leydig cells by Mullerian-inhibiting substance. Mol Cell Endocrinol 211:99-104
34. Keeney DS, Jenkins CM, Waterman MR 1995 Developmentally regulated expression of adrenal 17α-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136:4872-4879
35. Rahman NA, Kiiveri S, Rivero-Muller A, Levallet J, Vierre S, Kero J, Wilson DB, Heikinheimo M, Huhtaniemi I 2004 Adrenocortical tumorigenesis in transgenic mice expressing the inhibin α-subunit promoter/SV40 virus T-antigen transgene: Relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4. Mol Endocrinol 18:2553-2569
36. Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, Duvillard P, Chemes H, Bidart JM 2000 Anti-Müllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol 31:1202-1208
37. Tevosian SG, Albrecht KH, Crispino JD, Fujiwara Y, Eicher EM, Orkin SH 2002 Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. Devel 129:4627-4634
38. Tremblay JJ, Viger RS 1999 Transcription factor GATA-4 enhances Müllerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mol Endocrinol 13:1388-1401
39. Feng ZM, Wu AZ, Chen CL 1998 Testicular GATA-1 factor up-regulates the promoter activity of rat inhibin alpha-subunit gene in MA-10 Leydig tumor cells. Mol Endocrinol 12:378-390
40. Ketola I, Rahman N, Toppari J, Bielinska M, Porter-Tinge SB, Tapanainen JS, Huhtaniemi IT, Wilson DB, Heikinheimo M 1999 Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology 140:1470-1480
41. Shi Y, Massague J 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700
42. Gummow BM, Winnay JN, Hammer GD 2003 Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J Biol Chem 278:26572-26579
43. Rebar RW, Morandini IC, Benirschke K, Petze JE 1980 Reduced gonadotropins in athymic mice: prevention by thymic transplantation. Endocrinology 107:2130-2132
44. Tremblay JJ, Viger RS 2003 Novel roles for GATA transcription factors in the regulation of steroidogenesis. J Steroid Biochem Mol Biol 85:291-298
45. Matzuk MM, DeMayo FJ, Hadsell LA, Kumar TR 2003 Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biol Reprod 69:338-346
46. Mann RJ, Keri RA, Nilson JH 2003 Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHβCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology. Recent Prog Horm Res 58:343-375
47. Heikinheimo M, Ermolaeva M, Bielinska M, Rahman NA, Narita N, Huhtaniemi IT, Tapanainen JS, Wilson DB 1997 Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology 138:3505-3514
48. Tosh D, Slack JM 2002 How cells change their phenotype. Nat Rev Mol Cell Biol 3:187-194
49. Jabara S, Christenson LK, Wang CY, McAllister JM, Javitt NB, Dunaif A, Strauss JF, III 2003 Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab 88:484-492
50. Kaaijk EM, Sasano H, Suzuki T, Beek JF, van D, V 2000 Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study. Mol Hum Reprod 6:443-447
51. Katulski K, Bornstein S, Figiel M, Wand D, Warenik-Szymankiewicz A, Trzeciak WH 1998 Typical hormonal profiles are accompanied by increased immunoreactivity of theca folliculi steroid 17α-hydroxylase P450 in polycystic ovary syndrome. J Endocrinol Invest 21:304-309
52. Ascoli M, Fanelli F, Segaloff DL 2002 The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23:141-174
53. Wang L, Menon KM 2005 Regulation of luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid expression in the rat ovary: relationship to cholesterol metabolism. Endocrinology 146:423-431
54. Johnson DC, Crane LH 1995 Inhibitory and stimulatory effect of oestrogens upon ovarian 17α-hydroxylase/C17,20-lyase in immature hypophysectomized rats treated with gonadotrophin. J Endocrinol 145:59-67
55. Magoffin DA, Erickson GF 1982 Direct inhibitory effect of estrogen on LH-stimulated androgen synthesis by ovarian cells cultured in defined medium. Mol Cell Endocrinol 28:81-89
56. Matzuk MM, Finegold MJ, Mishina Y, Bradley A, Behringer RR 1995 Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis. Mol Endocrinol 9:1337-1345